These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 17198774

  • 1. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP.
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [Abstract] [Full Text] [Related]

  • 2. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A, Sujatha DI, Kanagarajan N, Vijayalakshmi MA, Ninan B.
    Ann Vasc Surg; 2009 Jan; 23(5):645-51. PubMed ID: 19467834
    [Abstract] [Full Text] [Related]

  • 3. Biochemical assessment of myocardial injury after cardiac surgery: effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy.
    Taggart DP.
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):651-9. PubMed ID: 11003744
    [Abstract] [Full Text] [Related]

  • 4. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F, Scolletta S, Tucci E, Lucidi M, Davoli G, Toscano T, Neri E, Muzzi L, Frati G.
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M, Ménasché P, Levy JH, Newman MF, Taylor KM, Haverich A, Chen JC, Shernan SK, Van de Werf F, van der Laan M, Todaro TG, Adams PX, Verrier ED.
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [Abstract] [Full Text] [Related]

  • 6. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
    Köksal H, Rahman A, Burma O, Halifeoğlu I, Bayar MK.
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
    [Abstract] [Full Text] [Related]

  • 7. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC, Carrier M, Kandzari DE, Emery R, Cote R, Heinonen T, Zettler M, Hasselblad V, Guertin MC, Harrington RA, MEND-CABG Investigators.
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
    [Abstract] [Full Text] [Related]

  • 8. Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart.
    Schachner T, Bonaros N, Ruetzler E, Weidinger F, Oehlinger A, Laufer G, Friedrich G, Bonatti J.
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1006-11. PubMed ID: 17903521
    [Abstract] [Full Text] [Related]

  • 9. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.
    Roth M, Kraus B, Scheffold T, Reuthebuch O, Klövekorn WP, Bauer EP.
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):642-50. PubMed ID: 11003743
    [Abstract] [Full Text] [Related]

  • 10. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT, Pexelizumab Study Investigators.
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [Abstract] [Full Text] [Related]

  • 11. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H, Hildebrand L, Schirdewahn C, Eitel I, Adams V, Fuernau G, Erbs S, Linke A, Diederich KW, Nowak M, Desch S, Gutberlet M, Schuler G.
    J Am Coll Cardiol; 2010 May 18; 55(20):2201-9. PubMed ID: 20466200
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ, Nielsen C.
    Eur J Cardiothorac Surg; 2004 Aug 18; 26(2):311-7. PubMed ID: 15296889
    [Abstract] [Full Text] [Related]

  • 13. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK, Carrier M, Chen JC, Haverich A, Levy JH, Menasché P, Shernan SK, Van de Werf F, Adams PX, Todaro TG, Verrier E.
    Ann Thorac Surg; 2006 Sep 18; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [Abstract] [Full Text] [Related]

  • 14. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
    Koramaz I, Pulathan Z, Usta S, Karahan SC, Alver A, Yaris E, Kalyoncu NI, Ozcan F.
    Ann Thorac Surg; 2006 Feb 18; 81(2):613-8. PubMed ID: 16427861
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K, Bianco G, Speziale G, Sampognaro R, Lavalle C, Guccione F, Dioguardi P, Ruvolo G.
    Eur J Cardiothorac Surg; 2007 Aug 18; 32(2):326-32. PubMed ID: 17576071
    [Abstract] [Full Text] [Related]

  • 16. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery.
    Fischer UM, Tossios P, Huebner A, Geissler HJ, Bloch W, Mehlhorn U.
    J Thorac Cardiovasc Surg; 2004 Jul 18; 128(1):103-8. PubMed ID: 15224028
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial.
    Cook RC, Humphries KH, Gin K, Janusz MT, Slavik RS, Bernstein V, Tholin M, Lee MK.
    Circulation; 2009 Sep 15; 120(11 Suppl):S163-9. PubMed ID: 19752363
    [Abstract] [Full Text] [Related]

  • 18. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 15; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 19. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
    Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F.
    J Thorac Cardiovasc Surg; 2008 Dec 15; 136(6):1541-8. PubMed ID: 19114204
    [Abstract] [Full Text] [Related]

  • 20. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
    Budeus M, Hennersdorf M, Perings S, Röhlen S, Schnitzler S, Felix O, Reimert K, Feindt P, Gams E, Lehmann N, Wieneke H, Sack S, Erbel R, Perings C.
    Eur Heart J; 2006 Jul 15; 27(13):1584-91. PubMed ID: 16760210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.